Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Shareprice

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Mar 26, 2021 3:02pm

208 Views

Post# 32887786

RE:RE:RE:RE:RE:RE:RE:RE:Shareprice

I will tell you all the cold hard truth on this from my own perspective in two weeks. I will test and double up.

I think you are right, and that might be why the 0.4% if proven safe and effective will have a big impact on pps.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects